Company intelligence / Profile preview

UCARE.AI

Singapore, Singaporeucare.ai ↗

Ownership: Private
Employees: ~11
Development stage: Commercial

Overview

UCARE.AI has demonstrated accurate hospital bill estimation at the point of admission across all Parkway Pantai hospitals in Singapore since 2018.\nIts rehospitalization risk prediction models have shown high accuracy for segments of the Singaporean population.\nThe company's anomaly detection system optimizes claims processing by flagging outlier medical claims related to over-servicing/fraud[2][5].

Therapeutic areas: OtherImmunology
Modalities: Non-pharmacological therapy
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Parkway Pantai Hospitals (Singapore) – deployment partner for cost predictor solutionParkway Shenton – partnership on continuous monitoring/disease management via personalized health risk assessmentsGreat Eastern Insurance – investor and customer reference

Beyond the preview

Go deeper on UCARE.AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on UCARE.AI.

Explore the full profile